Clinical trial • Phase I • Other
S072 for Pain
Phase I trial of S072 for Pain. None/Not specified-controlled. 64 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- Pain
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 14-04-2026
- First CTIS Authorization Date
- 16-04-2026
Trial design
None/Not specified-controlled Phase I trial across 1 site in Spain.
- Comparator
- None/Not specified
- Single Multiple Or Escalation Dose Combined
- Yes
- Target Sample Size
- 64
Eligibility
Recruits 64 No vulnerable populations selected; participants are healthy adult volunteers..
- Vulnerable Population
- No vulnerable populations selected; participants are healthy adult volunteers.
Recruitment
- Planned Sample Size
- 64
- Recruitment Window Months
- 23
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 64
Spain
- Earliest CTIS Part Ii Submission Date
- 14-04-2026
- Latest Decision Or Authorization Date
- 16-04-2026
- Processing Time Days
- 2
- Number Of Sites
- 1
- Number Of Participants
- 64
Sites
- Site Name
- Hospital Universitario La Paz
- Department Name
- Clinical Pharmacology
- Principal Investigator Name
- Alberto Borobia
- Principal Investigator Email
- alberto.borobia@idipaz.es
- Contact Person Name
- Alberto Borobia
- Contact Person Email
- alberto.borobia@idipaz.es
- Number Of Participants
- 64
Sponsor
Primary sponsor
- Full Name
- Sea4us Biotecnologia E Recursos Marinhos S.A.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Portugal
Investigational products
- Investigational Product Name
- S072
Related trials
Other published trials that may interest you.